Evidence map›Paper›PMID 22682699›Full record

ReviewDifferentiation; research in biological diversity2012

The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.

Monica M Laronda, Kenji Unno, Lindsey M Butler, Takeshi Kurita

Abstract readReview
In one paragraph

Review in Differentiation; research in biological diversity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experience.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2016
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Monica M LarondaDivision of Reproductive Biology Research, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Kenji Unno
Lindsey M Butler
Takeshi Kurita
Northwestern University · US

Funding

Xenograft Study on Growth-Control of Human Uterine LeiomyomataR01HD064402 · NICHD · OHIO STATE UNIVERSITY · PI KURITA, TAKESHI · 2010 to 2014
$1.6M
Molecular Etiology of Cervicovaginal Adenosis by in Utero Hormone ExposureR01CA154358 · NCI · OHIO STATE UNIVERSITY · PI KURITA, TAKESHI · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA154358NICHD NIH HHS R01 HD064402NICHD NIH HHS R01HD064402
6 · The paper itself

Abstract

Exposure to exogenous hormones during development can result in permanent health problems. In utero exposure to diethylstilbestrol (DES) is probably the most well documented case in human history. DES, an orally active synthetic estrogen, was believed to prevent adverse pregnancy outcome and thus was routinely given to selected pregnant women from the 1940s to the 1960s. It has been estimated that 5 million pregnant women worldwide were prescribed DES during this period. In the early 1970s, vaginal clear cell adenocarcinomas (CCACs) were diagnosed in daughters whose mother took DES during pregnancy (known as DES daughters). Follow-up studies demonstrated that exposure to DES in utero causes a spectrum of congenital anomalies in female reproductive tracts and CCACs. Among those, cervical and vaginal adenoses are most commonly found, which are believed to be the precursors of CCACs. Transformation related protein 63 (TRP63/p63) marks the cell fate decision of Müllerian duct epithelium (MDE) to become squamous epithelium in the cervix and vagina. DES disrupts the TRP63 expression in mice and induces adenosis lesions in the cervix and vagina. This review describes mouse models that can be used to study the development of DES-induced anomalies, focusing on cervical and vaginal adenoses, and discusses their molecular pathogenesis.

Indexed as

Prenatal Exposure Delayed EffectsAdenocarcinoma, Clear CellAnimalsDiethylstilbestrolEstrogens, Non-SteroidalFemaleGene Expression Regulation, NeoplasticHumansMicePhosphoproteinsPregnancyTrans-ActivatorsUterine Cervical NeoplasmsVaginal NeoplasmsDiethylstilbestrolEstrogens, Non-SteroidalPhosphoproteinsTrans-ActivatorsTrp63 protein, mouse

Identifiers

PMID22682699
PMCPMC3443265
OpenAlexW2032179492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.